Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates-Reference-Cited by-同舟云学术

Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates

Published:2021-03-26 Issue:13 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Duro-Castano A.¹^ORCID,Borrás C.²^ORCID,Herranz-Pérez V.³⁴^ORCID,Blanco-Gandía M. C.⁵^ORCID,Conejos-Sánchez I.¹^ORCID,Armiñán A.¹^ORCID,Mas-Bargues C.²^ORCID,Inglés M.⁶^ORCID,Miñarro J.⁶^ORCID,Rodríguez-Arias M.⁶^ORCID,García-Verdugo J. M.³^ORCID,Viña J.²,Vicent M. J.¹^ORCID

Affiliation:

1. Polymer Therapeutics Lab., Centro de Investigación Príncipe Felipe (CIPF), Av. Eduardo Primo Yúfera 3, 46012 Valencia, Spain.

2. Grupo de Investigación FRESHAGE, Departamento de Fisiología, Facultad de Medicina, Univ.. Valencia, CIBERFES-ISCIII, INCLIVA, Av. Blasco Ibáñez 15, 46010 Valencia, Spain.

3. Laboratory of Comparative Neurobiology, Cavanilles Institute of Biodiversity and Evolutionary Biology, Univ. València, CIBERNED, 46980 Valencia, Spain.

4. Predepartamental Unit of Medicine, Faculty of Health Sciences, Univ. Jaume I, 12071 Castelló de la Plana, Spain.

5. Departamento de Psicología y Sociología, Facultad de Ciencias Sociales y Humanas, Univ. Zaragoza, Teruel, Spain.

6. Unidad de Investigación Psicobiología de las Drogodependencias, Departamento de Psicobiología, Facultad de Psicología, Univ. Valencia, Valencia, Spain.

Abstract

LRP1-targeted St-Cl–polyglutamate conjugates as multivalent neuroprotective/neurotrophic therapeutics for Alzheimer’s disease.

Funder

H2020 European Research Council

Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana

Spanish National Plan for Scientific and Technical Research and Innovation

European Regional Development Fund (ERDF) included in the ERDF

EU Joint Programming Initiative

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference90 articles.

1. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

2. Alzheimer’s Statistics (2021); www.alzheimers.net/resources/alzheimers-statistics/) [accessed 13 January 2021]

3. Alzheimer's disease

4. A. Onur Keskin N. Durmaz G. Uncu E. Erzurumluoglu Z. Yıldırım N. Tuncer D. Özbabalık Adapınar Geriatric Medicine and Gerontology (IntechOpen 2019).

5. Alzheimer’s Disease, the “One-Molecule, One-Target” Paradigm, and the Multitarget Directed Ligand Approach

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of a poly-L-glutamic acid-based combination conjugate for hormone-responsive breast cancer treatment;Journal of Controlled Release;2024-11

2. PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease;Medicinal Chemistry;2024-10

3. Self-Assembled Type I Nanophotosensitizer with NIR-II Fluorescence Emission for Imaging-Guided Targeted Phototherapy of Glioblastoma;ACS Applied Nano Materials;2024-09-11

4. Precision drug delivery to the central nervous system using engineered nanoparticles;Nature Reviews Materials;2024-06-25

5. Programmable DNA Scaffolds Enable Orthogonal Engineering of Cell Membrane-Based Nanovesicles for Therapeutic Development;Nano Letters;2024-06-10